Display options
Cite
Krishnaveni D, Bhayal AC, Sri Manjari K, et al. MMP 9 Gene Promoter Polymorphism in Gastric Cancer. Indian J Clin Biochem. 2012;27(3):259-64doi: 10.1007/s12291-012-0210-2.
Krishnaveni, D., Bhayal, A. C., Sri Manjari, K., Vidyasagar, A., Uma Devi, M., Ramanna, M., Jyothy, A., Nallari, P., & Venkateshwari, A. (2012). MMP 9 Gene Promoter Polymorphism in Gastric Cancer. Indian journal of clinical biochemistry : IJCB, 27(3), 259-64. https://doi.org/10.1007/s12291-012-0210-2
Krishnaveni, D, et al. "MMP 9 Gene Promoter Polymorphism in Gastric Cancer." Indian journal of clinical biochemistry : IJCB vol. 27,3 (2012): 259-64. doi: https://doi.org/10.1007/s12291-012-0210-2
Krishnaveni D, Bhayal AC, Sri Manjari K, Vidyasagar A, Uma Devi M, Ramanna M, Jyothy A, Nallari P, Venkateshwari A. MMP 9 Gene Promoter Polymorphism in Gastric Cancer. Indian J Clin Biochem. 2012 Jul;27(3):259-64. doi: 10.1007/s12291-012-0210-2. Epub 2012 Apr 18. PMID: 26405384; PMCID: PMC4577507.
Copy Download .nbib Format: NLM
Share it on

Indian J Clin Biochem. 2012 Jul;27(3):259-64. doi: 10.1007/s12291-012-0210-2. Epub 2012 Apr 18.

MMP 9 Gene Promoter Polymorphism in Gastric Cancer.

Indian journal of clinical biochemistry : IJCB

D Krishnaveni, Amar Chand Bhayal, K Sri Manjari, A Vidyasagar, M Uma Devi, M Ramanna, A Jyothy, Pratibha Nallari, A Venkateshwari

Affiliations

  1. Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad, 500 016 India.
  2. Department of Gastroenterology, Gandhi Hospital, Hyderabad, 500 003 India.
  3. Department of Genetics, Osmania University, Hyderabad, 500 007 India.

PMID: 26405384 PMCID: PMC4577507 DOI: 10.1007/s12291-012-0210-2

Abstract

Matrix metalloproteinase-9 (gelatinase B) plays a key role in cancer invasion and metastasis by degrading the extracellular matrix and basement membrane barriers. A cytosine (C) > thymidine (T) single nucleotide polymorphism (SNP) at position -1562 in the MMP-9 promoter is reported to influence the expression of the gene. Genotyping of MMP-9 -1562 C→T promoter polymorphism in 140 gastric cancer patients and 132 healthy control subjects was carried out in order to evaluate its association with progression and development of gastric cancer. The SNP was genotyped by tetra-primer amplification refractory mutation system-polymerase chain reaction followed by agarose gel electrophoresis. Statistical methods were adopted to test for the significance of the results. Risk factor profile of the patients revealed age above 50 years, smoking, alcoholism as the factors associated with the disease. The distribution of genotype frequencies in gastric cancer patients were 28.7 % of CC, 45.5 % of CT and 25.7 % of TT, whereas in control subjects 31.8 % of CC, 53.03 % of CT and 15.15 % of TT, respectively. The allelic frequencies were 51.51 % of C and 48.48 % of T in patient group and 58.33 % of C and 41.66 % of T in controls respectively. The present study shows the possible association of epidemiological risk factors with gastric cancer. There is an increased frequency of T allele in the disease compared to control subjects. However, there is no association of the MMP-9 -1562 C→T promoter polymorphism in the development of gastric cancer.

Keywords: Gastric cancer; Matrix metalloproteinase-9; Metastasis; Polymorphism

References

  1. Ai Zheng. 2004 Nov;23(11):1233-7 - PubMed
  2. Cancer Lett. 2001 Jan;162 Suppl:S49-S55 - PubMed
  3. Circulation. 1999 Apr 13;99(14 ):1788-94 - PubMed
  4. Semin Oncol. 1996 Jun;23(3):281-91 - PubMed
  5. J Soc Gynecol Investig. 2006 Oct;13(7):523-9 - PubMed
  6. J Cell Sci. 1993 Apr;104 ( Pt 4):991-9 - PubMed
  7. Cancer Genet Cytogenet. 2004 Aug;153(1):26-31 - PubMed
  8. Br J Cancer. 2007 Sep 3;97(5):700-4 - PubMed
  9. Cancer Res. 2003 Dec 1;63(23):8221-5 - PubMed
  10. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 - PubMed
  11. Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):813-20 - PubMed
  12. J Biol Chem. 1991 Apr 25;266(12):7870-5 - PubMed
  13. Cancer Genet Cytogenet. 2008 Feb;181(1):31-5 - PubMed
  14. In Vivo. 2001 Jan-Feb;15(1):57-64 - PubMed
  15. Nucleic Acids Res. 1991 Oct 11;19(19):5444 - PubMed
  16. J Clin Invest. 1987 Dec;80(6):1644-50 - PubMed
  17. Cancer Biol Ther. 2007 Aug;6(8):1211-7 - PubMed
  18. Semin Oncol. 1996 Jun;23(3):316-24 - PubMed
  19. J Clin Invest. 1990 Nov;86(5):1496-502 - PubMed
  20. J Cancer Res Clin Oncol. 2005 Jan;131(1):19-25 - PubMed
  21. Br J Cancer. 2006 Sep 18;95(6):744-51 - PubMed
  22. Intern Med. 1996 Jun;35(6):443-8 - PubMed
  23. Methods Mol Biol. 2009;472:467-77 - PubMed
  24. Biochem J. 1989 Mar 1;258(2):463-72 - PubMed
  25. Int J Dev Biol. 2004;48(5-6):411-24 - PubMed
  26. J Clin Pathol. 1988 Jul;41(7):812-3 - PubMed
  27. J Immunol. 1991 Feb 15;146(4):1286-93 - PubMed
  28. J Biol Chem. 1989 Oct 15;264(29):17213-21 - PubMed

Publication Types